Shares in Novo Nordisk rose recently following the release of preliminary trial data for a new anti-obesity drug. The pharmaceuticals giant surpassed electric vehicle (EV) maker Tesla in terms of market value. Source: Euro News.
According to the news, the market value of Novo Nordisk stands at 60 thousand 4 billion dollars after the release of the trial data. At the same time Tesla’s market value was 56.9 billion dollars.
Novo Nordisk even outperforms LVMH and VISA.